FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection

View source ↗

Summary

FDA approved Hepcludex (bulevirtide-gmod) as the first treatment for chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or with compensat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis Delta Virus Infection

Drugs mentioned

• Hepcludex (bulevirtide)

Snippet

Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.